MeSH tree: D02.886.675
A drug called riluzole, commonly used to treat amyotrophic lateral sclerosis (ALS) and other motor neuron diseases, could also assist in recovery from spinal cord injuries, according to research from the University of Toronto's ...
Sep 16, 2025
0
24
Noonan syndrome with multiple lentigines (NSML) is a rare genetic disorder that causes short stature, distinctive facial features, and clusters of dark skin spots called lentigines. But its most serious impact is a dangerous ...
Sep 16, 2025
0
44
A study from The University of Texas at San Antonio Health Science Center indicates that changes in the body that lead to type 2 diabetes occur long before current diagnostic thresholds for prediabetes are met.
Sep 11, 2025
0
60
Some sugar substitutes may come with unexpected consequences for long-term brain health, according to a study published in Neurology. The study examined seven low- and no-calorie sweeteners and found that people who consumed ...
Sep 3, 2025
0
300
Findings could lead to earlier detection and treatment for those suffering from the serious eye condition.
Aug 20, 2025
0
20
Scientists in Ghent have achieved a breakthrough in sepsis research. In a study on mice, the researchers demonstrated that vitamin B1 (thiamine pyrophosphate, TPP) restores mitochondrial energy metabolism, drastically reduces ...
Jul 29, 2025
0
301
Eight different vitamins make up the B complex, and they all play crucial roles in the body, such as producing energy, keeping our nervous system healthy, and supporting cell development. If eight sounds like a lot to keep ...
Jul 29, 2025
0
32
COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it—the antiviral drug Paxlovid—is less clear.
Jul 24, 2025
0
55
Amyotrophic lateral sclerosis (ALS) is a devastating neurological disorder of unknown cause, in which motor nerve cells of the brain and spinal cord that transmit signals to muscles progressively degenerate. This weakens ...
Jul 22, 2025
0
11
For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical outcomes compared with conventional therapies, according to ...
Jul 21, 2025
0
12
